Pfizer Limited
Pfizer Limited is a Public Company limited by Shares company incorporated in 1950 and based in Maharashtra, India. Pfizer Limited operates in Chemical substances used in the manufacture of anti-biotic, manufacturing (NIC 24231) with authorized capital of ₹63.00 Cr and paid-up capital of ₹45.75 Cr. RegisterKaro's Compliance Health Score for the company is 35/100 (grade F), reflecting a weak compliance posture.
Pfizer - Provider of pharmaceutical products for multiple disease treatments. Public Company. Raised funding over 11 rounds from 18 investors.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Pfizer Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +35d | filed |
| MGT-7 | FY2024-25 | 24 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +19d | filed |
| MGT-7 | FY2023-24 | 20 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +33d | filed |
| MGT-7 | FY2022-23 | 20 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Pfizer Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 981879154 | ICICI Bank Ltd(Bank) | ₹17.11 Cr | 04 Jul 2021 | Satisfied |
| 275057785 | Axis Bank Ltd(Bank) | ₹23.30 Cr | 19 Sep 2019 | Open |
| 708738712 | State Bank of India(Bank) | ₹15.30 Cr | 04 Jul 2020 | Satisfied |
| 621778860 | Kotak Mahindra Bank Ltd(Bank) | ₹5.61 Cr | 19 Sep 2020 | Open |
| 315464042 | State Bank of India(Bank) | ₹12.31 Cr | 27 Jan 2020 | Open |
Charge IDs, lenders & amounts for Pfizer Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹29.03 Cr | ₹3.79 Cr | ₹10.41 Cr | ₹26.68 Cr | 364 |
| FY2023-24 | ₹25.05 Cr | ₹3.09 Cr | ₹20.74 Cr | ₹37.15 Cr | 33 |
| FY2022-23 | ₹21.26 Cr | ₹2.51 Cr | ₹11.00 Cr | ₹31.07 Cr | 30 |
| FY2021-22 | ₹22.88 Cr | ₹2.93 Cr | ₹8.15 Cr | ₹21.87 Cr | 182 |
Audited financials & ratios for Pfizer Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹29.03 Cr | ₹25.05 Cr | ₹21.26 Cr | ₹22.88 Cr |
| Other income | ₹50.69 L | ₹59.55 L | ₹42.16 L | ₹76.52 L |
| Total income | ₹29.54 Cr | ₹25.64 Cr | ₹21.68 Cr | ₹23.65 Cr |
| Total expenses | ₹24.69 Cr | ₹21.68 Cr | ₹18.47 Cr | ₹19.90 Cr |
| Profit before tax | ₹4.93 Cr | ₹4.02 Cr | ₹3.26 Cr | ₹3.80 Cr |
| Profit / (Loss) after tax | ₹3.79 Cr | ₹3.09 Cr | ₹2.51 Cr | ₹2.93 Cr |
| Balance sheet | ||||
| Equity / Net worth | ₹10.41 Cr | ₹20.74 Cr | ₹11.00 Cr | ₹8.15 Cr |
| Borrowings | ₹4.05 Cr | ₹3.78 Cr | ₹10.98 Cr | ₹2.81 Cr |
| Current liabilities | ₹8.38 Cr | ₹5.02 Cr | ₹8.36 Cr | ₹6.58 Cr |
| Total liabilities | ₹16.27 Cr | ₹16.40 Cr | ₹20.07 Cr | ₹13.73 Cr |
| Current assets | ₹13.71 Cr | ₹21.36 Cr | ₹10.88 Cr | ₹12.42 Cr |
| Cash & equivalents | ₹2.69 Cr | ₹5.12 Cr | ₹2.27 Cr | ₹2.93 Cr |
| Total assets | ₹26.68 Cr | ₹37.15 Cr | ₹31.07 Cr | ₹21.87 Cr |
| Employees | 364 | 33 | 30 | 182 |
Audited financials & ratios for Pfizer Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹29.03 Cr | +24.8% | +3.2% | +3.2% |
| Profit after Tax | ₹3.79 Cr | +9.6% | +10.0% | +20.7% |
| Net Worth | ₹10.41 Cr | -0.8% | +11.5% | +11.1% |
| Employees | 364 | +7.5% | +4.5% | +10.3% |
Audited financials & ratios for Pfizer Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹29.03 Cr | ₹3.79 Cr | +13.05% | -5.76% | +36.40% | +14.20% | 0.39 | ₹7.98 L |
| FY2023-24 | ₹25.05 Cr | ₹3.09 Cr | +12.35% | +8.30% | +14.91% | +8.33% | 0.18 | ₹75.90 L |
| FY2022-23 | ₹21.26 Cr | ₹2.51 Cr | +11.79% | +31.51% | +22.78% | +8.07% | 1.00 | ₹70.86 L |
| FY2021-22 | ₹22.88 Cr | ₹2.93 Cr | +12.78% | +0.31% | +35.90% | +13.37% | 0.34 | ₹12.57 L |
Audited financials & ratios for Pfizer Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 2 | 64,01,098 | 60.00% |
| Institutional Investors | 1 | 11,56,308 | 10.84% |
| Public & Others | 18 | 31,10,974 | 29.16% |
Promoter, institutional & public holding for Pfizer Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
228 peersTop 1 in Chemical substances used in the manufacture of anti-biotic, manufacturing
by healthView all ›Events & timeline
3External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.